BlossomHill Therapeutics reports wider 3Q loss, no product revenue
BlossomHill Therapeutics reported a wider net loss for the three months ended June 30, 2026 versus the year-ago quarter. The company also reported no product revenue for the periods presented.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.